- Home
- OSK vs HALO Comparison
OSK vs HALO Comparison
Compare OSK & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OSK
- HALO
- Stock Information
- Founded
- OSK 1917
- HALO 1998
- Country
- OSK United States
- HALO United States
- Employees
- OSK N/A
- HALO N/A
- Industry
- OSK Auto Manufacturing
- HALO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- OSK Consumer Discretionary
- HALO Health Care
- Exchange
- OSK Nasdaq
- HALO Nasdaq
- Market Cap
- OSK 7.3B
- HALO 6.4B
- IPO Year
- OSK N/A
- HALO N/A
- Fundamental
- Price
- OSK $98.68
- HALO $56.03
- Analyst Decision
- OSK Buy
- HALO Buy
- Analyst Count
- OSK 15
- HALO 9
- Target Price
- OSK $123.53
- HALO $60.89
- AVG Volume (30 Days)
- OSK 466.7K
- HALO 1.3M
- Earning Date
- OSK 01-30-2025
- HALO 02-18-2025
- Dividend Yield
- OSK 1.91%
- HALO N/A
- EPS Growth
- OSK 29.68
- HALO 61.71
- EPS
- OSK 10.30
- HALO 3.02
- Revenue
- OSK $10,598,900,000.00
- HALO $947,355,000.00
- Revenue This Year
- OSK $10.29
- HALO $23.12
- Revenue Next Year
- OSK N/A
- HALO $15.48
- P/E Ratio
- OSK $9.34
- HALO $18.37
- Revenue Growth
- OSK 12.82
- HALO 21.35
- 52 Week Low
- OSK $89.08
- HALO $33.15
- 52 Week High
- OSK $127.98
- HALO $65.53
- Technical
- Relative Strength Index (RSI)
- OSK 52.62
- HALO 65.15
- Support Level
- OSK $95.82
- HALO $54.96
- Resistance Level
- OSK $98.45
- HALO $56.39
- Average True Range (ATR)
- OSK 1.77
- HALO 1.52
- MACD
- OSK 1.00
- HALO 0.40
- Stochastic Oscillator
- OSK 88.05
- HALO 87.03
About OSK Oshkosh Corporation (Holding Company)Common Stock
Oshkosh is the top producer of access equipment, specialty vehicles, and military trucks. It serves diverse end markets, where it is typically the market share leader in North America, or, in the case of JLG aerial work platforms, a global leader. The company had manufactured joint light tactical vehicles for the us Department of Defense. However, Oshkosh recently lost the JLTV recompete, bringing into focus its us Postal Service contract, which calls for the electrification of us postal vehicles. The company reports in three segments—access equipment (52% of revenue), defense (22%), and vocational (27%)—and generated $9.6 billion in revenue in 2023.
About HALO Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with unmet medical needs, with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.